Neurotek

Neurotek is a health technology company specializing in advanced digital tools for cognitive and attention assessment. We combine neuroscience, data science, and scalable cloud infrastructure to empower clinicians with intelligent solutions that bring precision and efficiency to behavioral and neuropsychological evaluation. Our flagship product, MOXO, is a clinically validated digital attention assessment used in more than 50 countries and backed by over 100 peer-reviewed studies. Trusted by healthcare networks, clinics, and research institutions, MOXO helps professionals measure attention performance accurately and objectively - in-clinic or remotely without specialized hardware. For more than a decade, Neurotek has been advancing the science of attention and executive function assessment through continuous innovation, real-world validation, and a commitment to accessibility and inclusivity in mental-health care. Our Mission is to make cognitive assessment smarter, faster, and more accessible - empowering clinicians worldwide with scientifically validated digital tools that improve diagnostic confidence and patient outcomes.